NCT06606236

Brief Summary

Objective. This study assessed the neuropeptide Y (NPY) expression in healthy human dental pulp following tooth bleaching with three in-office hydrogen peroxide-based systems: Opalescence Boost© (Ultradent Products, South Jordan, UT), Pola Office© (SDI, Victoria, Australia), and Zoom© (Zoom! Bleaching System; Discuss Dental, Culver City, CA). Materials and Methods. Forty dental pulps were collected from healthy premolars scheduled for extraction for orthodontic reasons. Teeth were divided into four groups containing ten healthy premolars each: Control group (n= 10): the teeth were not exposed to dental bleaching agents (healthy pulps assessed for normal/basal NPY values). Pola Office system group (n= 10): application of Pola office (35% H2O2) for 8 minutes. Opalescent Boost system group (n= 10): application of Opalescent Boost (40% H2O2) for 20 minutes. Zoom system group (n= 10): application of Zoom! (25% H2O2 + cold blue light) for 15 minutes. The investigators rigorously followed the manufacturer's instructions for all bleaching systems. Following the extractions, the pulpal tissue was collected, placed in a 4% formaldehyde solution in Eppendorf tubes, and processed. NPY levels were measured using enzyme-linked immunosorbent assay (ELISA).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 5, 2024

Completed
23 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2024

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

September 14, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

September 20, 2024

Completed
Last Updated

September 23, 2024

Status Verified

September 1, 2024

Enrollment Period

23 days

First QC Date

September 14, 2024

Last Update Submit

September 19, 2024

Conditions

Keywords

NPYDental PulpDental BleachingNeurogenic Inflammation

Outcome Measures

Primary Outcomes (1)

  • Neuropeptide Y expression

    Measurement of the increase or not of NPY expression compared to the control group (teeth without intervention)

    8-20 minutes

Study Arms (4)

Control group

NO INTERVENTION

The teeth were not exposed to dental bleaching agents (healthy pulps with normal/basal NPY values). n=10

Pola Office system group

EXPERIMENTAL

Application of Pola office n=10

Other: H2O2 at 35% for 8 minutes

Opalescent Boost system group

EXPERIMENTAL

Application of Opalescent Boost n=10

Other: H2O2 at 40% for 20 minutes

Zoom system group

EXPERIMENTAL

Application of Zoom! n=10

Other: H2O2 at 25% plus cold blue light for 15 minutes

Interventions

The investigators rigorously followed the manufacturer's instructions for all bleaching systems.

Pola Office system group

The investigators rigorously followed the manufacturer's instructions for all bleaching systems.

Opalescent Boost system group

The investigators rigorously followed the manufacturer's instructions for all bleaching systems.

Zoom system group

Eligibility Criteria

Age18 Years - 27 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Dental pulps were collected from non-smoking donors
  • Patients who need premolar extractions for orthodontic purposes.
  • These premolars must meet the following requirements:
  • Caries and restoration-free,
  • Complete root development (visually and radiographically confirmed),
  • Normal response to sensitivity testing.

You may not qualify if:

  • Evidence of periodontal disease,
  • Traumatic occlusion
  • Previous orthodontic force application.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Facultad de Odontologia, Unicoc

Bogotá, Colombia

Location

Related Publications (13)

  • Basting RT, Amaral FL, Franca FM, Florio FM. Clinical comparative study of the effectiveness of and tooth sensitivity to 10% and 20% carbamide peroxide home-use and 35% and 38% hydrogen peroxide in-office bleaching materials containing desensitizing agents. Oper Dent. 2012 Sep-Oct;37(5):464-73. doi: 10.2341/11-337-C. Epub 2012 May 18.

    PMID: 22616927BACKGROUND
  • Bharti R, Wadhwani K. Spectrophotometric evaluation of peroxide penetration into the pulp chamber from whitening strips and gel: An in vitro study. J Conserv Dent. 2013 Mar;16(2):131-4. doi: 10.4103/0972-0707.108192.

    PMID: 23716964BACKGROUND
  • Buchalla W, Attin T. External bleaching therapy with activation by heat, light or laser--a systematic review. Dent Mater. 2007 May;23(5):586-96. doi: 10.1016/j.dental.2006.03.018. Epub 2006 Jul 3.

    PMID: 16820199BACKGROUND
  • Caviedes-Bucheli J, Munoz HR, Azuero-Holguin MM, Ulate E. Neuropeptides in dental pulp: the silent protagonists. J Endod. 2008 Jul;34(7):773-88. doi: 10.1016/j.joen.2008.03.010.

    PMID: 18570980BACKGROUND
  • Caviedes-Bucheli J, Ariza-Garcia G, Restrepo-Mendez S, Rios-Osorio N, Lombana N, Munoz HR. The effect of tooth bleaching on substance P expression in human dental pulp. J Endod. 2008 Dec;34(12):1462-5. doi: 10.1016/j.joen.2008.09.013. Epub 2008 Oct 31.

    PMID: 19026874BACKGROUND
  • Caviedes-Bucheli J, Gomez-Sosa JF, Azuero-Holguin MM, Ormeno-Gomez M, Pinto-Pascual V, Munoz HR. Angiogenic mechanisms of human dental pulp and their relationship with substance P expression in response to occlusal trauma. Int Endod J. 2017 Apr;50(4):339-351. doi: 10.1111/iej.12627. Epub 2016 Apr 2.

    PMID: 26953220BACKGROUND
  • Caviedes-Bucheli J, Lombana N, Azuero-Holguin MM, Munoz HR. Quantification of neuropeptides (calcitonin gene-related peptide, substance P, neurokinin A, neuropeptide Y and vasoactive intestinal polypeptide) expressed in healthy and inflamed human dental pulp. Int Endod J. 2006 May;39(5):394-400. doi: 10.1111/j.1365-2591.2006.01093.x.

    PMID: 16640639BACKGROUND
  • Caviedes-Bucheli J, Lopez-Moncayo LF, Munoz-Alvear HD, Hernandez-Acosta F, Pantoja-Mora M, Rodriguez-Guerrero AS, Lopez-Ordonez A, Diaz LE, Gomez-Sosa JF, Munoz HR. Expression of early angiogenesis indicators in mature versus immature teeth. BMC Oral Health. 2020 Nov 12;20(1):324. doi: 10.1186/s12903-020-01313-1.

    PMID: 33183306BACKGROUND
  • Donato MV, Dos Reis-Prado AH, Abreu LG, de Arantes LC, Goto J, Chaves HGDS, Cintra LTA, Briso ALF, Peixoto IFDC, Benetti F. Influence of dental bleaching on the pulp tissue: A systematic review of in vivo studies. Int Endod J. 2024 Jun;57(6):630-654. doi: 10.1111/iej.14061. Epub 2024 Mar 12.

    PMID: 38470103BACKGROUND
  • El-Karim I, Lundy FT, Linden GJ, Lamey PJ. Extraction and radioimmunoassay quantitation of neuropeptide Y (NPY) and vasoactive intestinal polypeptide (VIP) from human dental pulp tissue. Arch Oral Biol. 2003 Mar;48(3):249-54. doi: 10.1016/s0003-9969(02)00213-3.

    PMID: 12648563BACKGROUND
  • Farah RI, Elwi H. Spectrophotometric evaluation of color changes of bleach-shade resin-based composites after staining and bleaching. J Contemp Dent Pract. 2014 Sep 1;15(5):587-94. doi: 10.5005/jp-journals-10024-1584.

    PMID: 25707831BACKGROUND
  • Fernandes AMM, Vilela PGF, Valera MC, Bolay C, Hiller KA, Schweikl H, Schmalz G. Effect of bleaching agent extracts on murine macrophages. Clin Oral Investig. 2018 May;22(4):1771-1781. doi: 10.1007/s00784-017-2273-1. Epub 2017 Dec 1.

    PMID: 29196947BACKGROUND
  • Galler KM, Weber M, Korkmaz Y, Widbiller M, Feuerer M. Inflammatory Response Mechanisms of the Dentine-Pulp Complex and the Periapical Tissues. Int J Mol Sci. 2021 Feb 2;22(3):1480. doi: 10.3390/ijms22031480.

    PMID: 33540711BACKGROUND

MeSH Terms

Conditions

Neurogenic InflammationDental Pulp Diseases

Condition Hierarchy (Ancestors)

Neurologic ManifestationsNervous System DiseasesInflammationPathologic ProcessesPathological Conditions, Signs and SymptomsTooth DiseasesStomatognathic Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Masking Details
The bleaching agent was applied using specific devices, with only the laboratory staff able to identify the corresponding group codes, which consisted of letters and numbers.
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Model Details: Sample Collection: Teeth were anesthetized after tooth bleaching using 3% mepivacaine without a vasoconstrictor for maxillary premolars and an inferior alveolar nerve block for mandibular premolars. 10 minutes later, teeth were extracted within 5 minutes. For the control group, extractions also occurred ten minutes post-anesthesia. After extraction, teeth were rinsed with 5.25% sodium hypochlorite to eliminate any remaining periodontal ligament. Teeth were sectioned with a Zekrya bur, and pulp tissue was collected with a sterile excavator, placed in a 1 ml 4% paraformaldehyde Eppendorf tube, and stored at -70°C. ELISA: Fifty microliters of each standard, blank, and sample were added to wells in duplicate. A working solution with biotinylated antibody was added, and the plate was incubated at 37°C. After washing, horseradish peroxidase-conjugated solution was added, followed by substrate and stop solution. The optical density of each well was measured at 450 nm.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

September 14, 2024

First Posted

September 20, 2024

Study Start

February 5, 2024

Primary Completion

February 28, 2024

Study Completion

February 28, 2024

Last Updated

September 23, 2024

Record last verified: 2024-09

Data Sharing

IPD Sharing
Will not share

Locations